IR Beam Used Before Peripheral Intravenous Catheter Application on Vein Visibility

August 21, 2024 updated by: Sule BIYIK BAYRAM, Karadeniz Technical University

Karadeniz Technical University - Tubitak Student Project

The study will be conducted in the Oncology and Cardiovascular Surgery (CVS) services of a university hospital. In the research, 30 patients will constitute the control group and 30 patients will constitute the experimental group. A nurse working in the clinics where the study will be conducted will perform the PIVK procedure, and we will randomly select the control and experimental groups and apply light to the area where the PIVK will be applied to the patients in the experimental groups with a flashlight that emits infrared rays for 10 minutes. The nurse will not be aware of whether the radiation application was made to the patient or not. The veins will be evaluated by the nurse performing PIVK. We will fill out the necessary forms in ANNEX 1 (control group) and APPENDIX 2 (experimental group) while the PIVK procedure is applied. After the procedure is completed, the patient's pain, anxiety and satisfaction level during the procedure will be marked. The data will be entered into the SPSS program and evaluated with statistical tests. According to the results, the effect of IR rays used before PIVK application on the patient's pain, anxiety and satisfaction and on the procedure time spent by the nurse for the application will be determined.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

A nurse from the ward where the study will be conducted will be contacted and a meeting of approximately 20 minutes will be held about the study. The nurse will fill out the forms before and after inserting the catheter into the patient. Routine procedures such as tourniquet, hand opening and closing will be applied to the control group before catheter application. In the experimental group, catheter application will be made after the IR beam is applied.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Trabzon, Turkey
        • Şule
        • Sub-Investigator:
          • Hüdanur TOSUN
        • Contact:
    • Ortahisar
      • Trabzon, Ortahisar, Turkey, 61080
        • Şule BIYIK BAYRAM
        • Contact:
        • Sub-Investigator:
          • Hüdanur TOSUN
    • Üniversite
      • Trabzon, Üniversite, Turkey, 61080
        • Karadeniz Technical University Faculty of Health Sciences
        • Contact:
        • Principal Investigator:
          • Merve ÇİÇEK

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Are between the ages of 18-70,

  • PIVK will be inserted,
  • Not receiving anticoagulant treatment,
  • Does not have diabetes or peripheral neuropathy,
  • No signs of infiltration or thrombophlebitis in the extremity where IR beam will be used,
  • Dialysis patients without arteriovenous fistula,
  • Does not have any communication problems and whose mental level does not cause any problems in participating in the research,
  • Patients who volunteer to participate in the research will be recruited.

Exclusion Criteria:

  • Sudden movements during PICK insertion,
  • Missing patient data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IR beam used before peripheral intravenous catheter application on vein visibility
IR beam application
Use of IR beam before peripheral intravenous catheter application
Other Names:
  • IR beam
No Intervention: control
Only parenteral catheter application

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of IR beam used before peripheral intravenous catheter application
Time Frame: 6 mounths
question form
6 mounths

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of IR beam on pain
Time Frame: 6 mounths
Pain scale
6 mounths
Effect of IR beam on anxiety
Time Frame: 6 mounths
Anxiety scale
6 mounths
Effect of IR beam on satisfaction
Time Frame: 6 mounths
Satisfaction scale
6 mounths
Effect of IR beam on application
Time Frame: 6 mounth
Question form
6 mounth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sule BIYIK BAYRAM, Karadeniz Technical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

September 15, 2024

Study Completion (Estimated)

September 30, 2024

Study Registration Dates

First Submitted

January 15, 2024

First Submitted That Met QC Criteria

August 21, 2024

First Posted (Actual)

August 23, 2024

Study Record Updates

Last Update Posted (Actual)

August 23, 2024

Last Update Submitted That Met QC Criteria

August 21, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Karadeniz Tek. Univ. 3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Questionnaire

Clinical Trials on randomised study, two group (experimental and control)

Subscribe